Home page > Europe and Health | Health, wealth and equity | Health friendly research and innovation | EU Funding and programmes | Irish Presidency priorities


Please find all related articles below.

EPHA position on the European Research Area

EPHA answered the DG Research consultation on the European Research Area. In the EPHA response, the role of CSOs and the importance of health research are highlighted. In its position, EPHA highlights the following points: Research and innovation should address the most pressing societal challenges benefiting all members of society; Energy and climate change along with population ageing and health are some of our biggest societal challenges and must be addressed by the ERA to (...)

Horizon 2020: will broader innovation improve health and wellbeing?

€31.7 billion will be allocated to tackling the major issues affecting the lives of European citizens and €8.5 billion euros are earmarked to health.


EPHA explainer - EU funds to support NGOs

There are many ways in which the EU supports Non Governmental Organisations to operate in Europe. This article details what they are, who is elligible and how organisations can apply.


European Antibiotic Awareness Day 2011

On 17 November 2011 the European Commission will launch its Strategy on Antimicrobial Resistance (AMR) to coincide with this year’s European Antibiotic Awareness Day (EAAD). Antimicrobiral resistance represents a growing public health concern and the 2011 EAAD will be focused on one way of adressing the issue - national initiatives to promote the prudent use of antibiotics. An event is being held to mark the EEAD and the launch of the Commission’s Strategy on Antimicrobial (...)

Alcohol, work and productivity: new report

Reducing the negative impact of alcohol on the workplace is one of five priorities picked out in the EU strategy to support Member States in reducing alcohol related harm and the Science Group of the European Alcohol and Health Forum (EAHF) has been tasked to produce a scientific opinion on ’Alcohol, work and productivity". Reducing the negative impact of alcohol on the workplace is one of five priorities picked out in the EU strategy to support Member States in reducing alcohol (...)
Also about: alcohol , youth , workplace

“Horizon 2020: Investing in the common good” Treating knowledge as a public good in EU research and innovation

Health Action International, an EPHA member and the Transatlantic Consumer Dialogue, an EPHA partner are co-organising an event on the future Horizons 2020 research programme. MEP Luigi Berlinguer (S&D IT) & MEP Philippe Lamberts (Greens/EFA BE) are hosting: “Horizon 2020: Investing in the common good” Treating knowledge as a public good in EU research and innovation Horizon (...)

New EU Communication on ’Partnerships’ in Research: towards increasing public private partnerships?

The European Commission recently published a new Communication entitled ’Partnering in research and innovation’, which aims to highlights the importance of partnering in European Research and Innovation. The Commission intends to encourage public and private actors to collaborate at European level to apply research and innovation solutions to major challenges facing society has been issued by the European Commission. The Commission Communication Partnering in research and (...)
Also about: EU budget

EMA Patients’ and Consumers’ Working Party Meeting September 2011

On Tuesday 13 September the European Medicines Agency convened a meeting of its Human Scientific Committees’ Working Party with Patients’ and Consumers’ Organisations (PCWP). The meeting addressed a number of different issues on the European Medicines’ Agency agenda which affect patients’ and consumers’ organisations. The meeting covered 3 areas of the agencies work: 1. Pharmacovigilance legislation A presentation was given on how patient reporting can (...)

Research organisations launch joint statement on clinical trials

EPHA members Cancer Research UK and European CanCer Organisation (ECCO) have joined together with other non-commercial and commercial organisations to produce a joint statement on the revision of the EU Clinical Trials Directive. The 16 signing organisations, which include many pan-European organisations, have urged the European Commission to overhaul the Clinical Trials Directive 2001/20/EC to remove some of the administrative burden of setting up and conducting research. They argue that (...)

Pressure mounts for a new form of medical innovation to improve access to medicines

A second meeting has been hosted in the European Parliament by Carl Schlyter (Greens-EFA, Sweden) on the subject of improving access to medicines though Medical Innovation Prizesand civil society is uniting to put pressure on the European Institutions to support a model of medical innovation which meets public health need. The meeting was co-organised by EPHA member Health Action International (HAI) an independent, global network working to increase access to essential medicines and (...)